Morbidity and mortality associated with influenza exposure in long-term care facilities for dependant elderly people

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 28, Issue 9, 2009, Pages 1077-1086

  Gaillat, J ^a   Chidiac, C ^b   Fagnani, F ^c   Pecking, M ^d   Salom, M ^e   Veyssier, P ^f   Carrat, F ^g  

^a Centre Hospitalier de la Région Annecienne   (France)

^b CROIX ROUSSE HOSPITAL   (France)

^c CEMKA EVAL   (France)

^d Roche   (France)

^e Centre de Gérontologie   (France)

^f Centre Hospitalier Compiegne   (France)

^g HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; OSELTAMIVIR;

AGED; AGING; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; EPIDEMIC; EXPOSURE; FEMALE; FRANCE; HEALTH CARE FACILITY; HOSPITALIZATION; HUMAN; INFLUENZA; INFLUENZA VIRUS; LONG TERM CARE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTICENTER STUDY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESIDENT; RISK FACTOR; TREATMENT DURATION; VACCINATION;

AGED; AGED, 80 AND OVER; FEMALE; HOSPITALIZATION; HUMANS; INFLUENZA, HUMAN; LONG-TERM CARE; LONGITUDINAL STUDIES; MALE; PROSPECTIVE STUDIES;

EID: 70349653158     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-009-0751-3     Document Type: Article

References (32)

1. Nicholson KG (1998) Human influenza. In: Nicholson KG, Webster RG, Hay AJ (eds) Textbook of influenza. Blackwell Science, Oxford, pp 219-264
2. L Simonsen K Fukuda LB Schonberger, et al. 2000 The impact of influenza epidemics on hospitalizations J Infect Dis 181 831 837 10.1086/315320 10720501 10.1086/315320 1:STN:280:DC%2BD3c7oslKgug%3D%3D (Pubitemid 30194462)
3. WW Thompson DK Shay E Weintraub, et al. 2004 Influenza-associated hospitalizations in the United States JAMA 292 1333 1340 10.1001/jama.292.11. 1333 15367555 10.1001/jama.292.11.1333 1:CAS:528:DC%2BD2cXns12rs7g%3D (Pubitemid 39223224)
4. WW Thompson DK Shay E Weintraub, et al. 2003 Mortality associated with influenza and respiratory syncytial virus in the United States JAMA 289 179 186 10.1001/jama.289.2.179 12517228 10.1001/jama.289.2.179 (Pubitemid 36068705)
5. AR Falsey RM McCann WJ Hall, et al. 1995 Acute respiratory tract infection in daycare centers for older persons J Am Geriatr Soc 43 30 36 7806736 1:STN:280:DyaK2M7gsFCitg%3D%3D
6. MR Griffin CS Coffey KM Neuzil, et al. 2002 Winter viruses: influenza- and respiratory syncytial virus-related morbidity in chronic lung disease Arch Intern Med 162 1229 1236 10.1001/archinte.162.11.1229 12038940 10.1001/archinte.162.11.1229
7. F Carrat 2002 L'impact sanitaire et économique de la grippe Virologie 6 S97 S104
8. L Simonsen MJ Clarke LB Schonberger, et al. 1998 Pandemic versus epidemic influenza mortality: a pattern of changing age distribution J Infect Dis 178 53 60 9652423 1:STN:280:DyaK1czhsVGgsw%3D%3D
9. L Simonsen TA Reichert C Viboud, et al. 2005 Impact of influenza vaccination on seasonal mortality in the US elderly population Arch Intern Med 165 265 272 10.1001/archinte.165.3.265 15710788 10.1001/archinte.165.3.265 (Pubitemid 40216277)
10. WH Barker H Borisute C Cox 1998 A study of the impact of influenza on the functional status of frail older people Arch Intern Med 158 645 650 10.1001/archinte.158.6.645 9521230 10.1001/archinte.158.6.645 1:STN:280:DyaK1c7otVGhtA%3D%3D (Pubitemid 28144823)
11. B Christenson P Lundbergh J Hedlund, et al. 2001 Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study Lancet 357 1008 1011 10.1016/S0140- 6736(00)04237-9 11293594 10.1016/S0140-6736(00)04237-9 1:STN:280: DC%2BD3M3ivV2jsQ%3D%3D (Pubitemid 32285394)
12. J Nordin J Mullooly S Poblete, et al. 2001 Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans J Infect Dis 184 665 670 10.1086/323085 11517426 10.1086/323085 1:STN:280: DC%2BD3Mvnt1Srsw%3D%3D (Pubitemid 32826416)
13. SE Ellis CS Coffey EF Mitchel Jr, et al. 2003 Influenza- and respiratory syncytial virus-associated morbidity and mortality in the nursing home population J Am Geriatr Soc 51 761 767 10.1046/j.1365-2389.2003.51254.x 12757561 10.1046/j.1365-2389.2003.51254.x (Pubitemid 36693424)
14. BEH (2005) Calendrier vaccinal 2005 et autres avis du Conseil supérieur d'hygiène publique de France relatifs à la vaccination. Bulletin épidémiologique hebdomadaire (BEH) 29-30:145. Available online at: http://www.invs.sante.fr/beh/2005/29-30/beh-29- 30-2005.pdf
15. Advisory Committee on Immunization Practices Department of Health and Human Services Centers for Disease Control and Prevention 2005 Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Morb Mortal Wkly Rep 54 1 44
16. WHO 2005 Influenza vaccines Wkly Epidemiol Rec 80 279 287
17. K Goodwin C Viboud L Simonsen 2006 Antibody response to influenza vaccination in the elderly: a quantitative review Vaccine 24 1159 1169 10.1016/j.vaccine.2005.08.105 16213065 10.1016/j.vaccine.2005.08.105 1:CAS:528:DC%2BD28Xhtleiurg%3D (Pubitemid 43202262)
18. T Jefferson D Rivetti A Rivetti, et al. 2005 Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review Lancet 366 1165 1174 10.1016/S0140-6736(05)67339-4 16198765 10.1016/S0140-6736(05)67339-4 1:STN:280:DC%2BD2MrisFWisQ%3D%3D (Pubitemid 41393594)
19. Groupe de Travail 2005 Taking care of influenza in the context of a pandemic in 2005. Full text Med Mal Infect 35 Suppl 4 S245 S273
20. Conseil Supérieur d'Hygiène Publique de France (2004) Prophylaxie chez les personnes à risque lors d'une épidémie de grippe dans une collectivité, en période de circulation du virus grippal. Direction Générale de la Sante
21. W Dab P Quenel JM Cohen, et al. 1991 A new influenza surveillance system in France: the Ile-de-France "GROG". 2. Validity of indicators (1984-1989) Eur J Epidemiol 7 579 587 10.1007/BF00218667 1783052 10.1007/BF00218667 1:STN:280:DyaK387ks1Ggtw%3D%3D
22. C Hannoun W Dab JM Cohen 1989 A new influenza surveillance system in France: the Ile-de-France "GROG". 1. Principles and methodology Eur J Epidemiol 5 285 293 10.1007/BF00144828 2792306 10.1007/BF00144828 1:STN:280:DyaK3c%2FgsFymtg%3D%3D
23. F Carrat A Flahault E Boussard, et al. 1998 Surveillance of influenza-like illness in France. The example of the 1995/1996 epidemic J Epidemiol Community Health 52 Suppl 1 32S 38S 9764269
24. Réseau Sentinelles INSERM. Nombre de cas (extrapolé) de Syndromes grippaux (grippe clinique) de toutes les régions pendant les semaines du 200453 au 200517. Tableaux de données. Available online at: http://websenti.b3e.jussieu.fr/sentiweb/?rub=33
25. A Flahault F Carrat AJ Valleron 2002 Système d'information pour la sécurité sanitaire: l'exemple de la grippe Virologie 6 S112 S118
26. Gail MH, Bénichou J (2000) Encyclopedia of epidemiologic methods. Wiley, Chichester
27. CNAM. L'assurance maladie lance la campagne de vaccination antigrippale 2005. Available online at: http://www.ameli.fr
28. CDC 2007 Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007 MMWR Recomm Rep 56 1 54
29. National Institute for Health and Clinical Excellence (2007) Zanamivir, oseltamivir and amantadine for the treatment of influenza (a review of existing guidance no. 58). Final scope
30. NJ Cooper AJ Sutton KR Abrams, et al. 2003 Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials BMJ 326 1235 10.1136/bmj.326.7401.1235 12791735 10.1136/bmj.326.7401.1235 1:CAS:528:DC%2BD3sXlslCitLc%3D
31. AS Monto 2003 The role of antivirals in the control of influenza Vaccine 21 1796 1800 10.1016/S0264-410X(03)00075-6 12686097 10.1016/S0264-410X(03)00075- 6 1:CAS:528:DC%2BD3sXis12gtLc%3D (Pubitemid 36398376)
32. JJ Treanor FG Hayden PS Vrooman, et al. 2000 Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group JAMA 283 1016 1024 10.1001/jama.283.8.1016 10697061 10.1001/jama.283.8.1016 1:CAS:528:DC%2BD3cXhs1Grsb4%3D